Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
For the nine months, sales was INR 1,852.64 million compared to INR 2,560.73 million a year ago. Revenue was INR 1,870.9 million compared to INR 2,579.65 million a year ago. Net income was INR 25.32 million compared to INR 34.14 million a year ago. Basic earnings per share from continuing operations was INR 1 compared to INR 1.34 a year ago. Diluted earnings per share from continuing operations was INR 1 compared to INR 1.34 a year ago.